|Bid||127.00 x 100|
|Ask||131.43 x 100|
|Day's Range||129.02 - 130.25|
|52 Week Range||96.93 - 139.00|
|PE Ratio (TTM)||48.51|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Allergan (AGN) is a leading pharmaceuticals company involved with pharmaceuticals, over-the-counter products, eye care, and aesthetics products.
From a trend perspective, the IBB and thus many large cap biotech firms including CELG stock remain both long-term and medium-term bullish. On the multiyear chart, we see that CELG stock remains trending higher but in recent months has struggled to overcome its previous all-time highs from July 2015. In other words, what I am looking for in CELG stock in coming weeks or months is a strong bullish reversal on a weekly closing basis, possibly followed by another week of follow-through buying to confirm that the stock may be ready for a renewed leg higher to new all-time highs.
Technology stocks led the S&P 500 on Tuesday, but in exchange-traded fund land, those tracking biotech stocks were the real winners. The SPDR S&P Biotech ETF (XBI) and First Trust NYSE Arca Biotechnology ...